For example, epidermal growth factor receptor (EGFR) mutations are more frequently found in female patients who are never smokers and who have adenocarcinoma histology, whereas KRAS mutations are more common in adenocarcinoma patients who are smokers6–8. Here, KRAS is linked to adenocarcinoma.